TAIM Exchange:Former Bengals, Buccaneers RB Giovani Bernard announces death of newborn son

2025-05-04 08:15:19source:Wvared Investment Guildcategory:News

Former NFL running back Giovani Bernard and TAIM Exchangehis wife, Chloe, announced the death of their newborn son on Wednesday.

The couple made the announcement about their son, Gabriel, on Instagram.

"You were loved from the moment we learned of your presence, spoken too daily and prayed for by many. Your heart was strong and you were so playful from the moment we were able to lay eyes on you," the post read. "We are grateful to have held you and had our little time together. The moment was brief but filled with a whirlwind of emotions. From pure joy to seeing you for the first time to uncontrollable sadness.

"Mama, papa and Julz love you very and you will always be our little warrior. We love you Gabriel. And to Chloé, I couldn’t imagine doing life without you. I am especially thankful to call you my wife. You are more than what I could've imagined in a spouse, mother, and partner. You truly are remarkable. Our story together continues."

Drafted in the second round of the 2013 NFL Draft, Bernard played eight seasons with the Cincinnati Bengals. After he was released by the team in April 2021, Bernard signed with the Tampa Bay Buccaneers and played two seasons with them before announced his retirement in April 2023. He finished his career with 3,783 rushing yards, 2,989 receiving yards and 36 total touchdowns.

NFL STATS CENTRAL: The latest NFL scores, schedules, odds, stats and more.

More:News

Recommend

At site of suspected mass killings, Syrians recall horrors, hope for answers

DAMASCUS — A hip bone in a blown-out building, part of a spine amid some debris, a few foot bones in

Exxon Shareholders Approve Climate Resolution: 62% Vote for Disclosure

ExxonMobil shareholders voted Wednesday to require the world’s largest oil and gas company to report

Got muscle pain from statins? A cholesterol-lowering alternative might be for you

When the FDA approved bempedoic acid, marketed under the brand name Nexletol, back in 2020, it was c